Therapy Areas: Allergy
12 March 2024 - Allergy Therapeutics plc (AIM: AGY), a UK-based biotechnology company that specialises in allergy vaccines, announced on Tueday that it has commenced subcutaneous dosing of peanut alle...
11 March 2024 - Celltrion USA, a United States subsidiary of South Korean biopharmaceutical company Celltrion, announced on Sunday that it has submitted a Biologics License Application (BLA) for CT-P3...
1 March 2024 - Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), a United States-based biotechnology company, announced on Thursday that it has named Kyle Jenne as its new executive vice president, chief gl...
13 December 2023 - Allergy Therapeutics plc (AIM: AGY), a UK based biotechnology company that specialises in allergy vaccines, on Wednesday announced positive outcomes from the G306 Phase III trial of...
21 November 2023 - NeoImmuneTech, Inc. (NIT), a US-based, clinical-stage T cell-focused biopharmaceutical company, announced on Monday that it has received Orphan Drug Designation (ODD) from the US Fo...
14 November 2023 - Allergy Therapeutics plc (AIM: AGY), a biotechnology company that specialises in allergy vaccines, on Tuesday announced interim top-line results from the G306 Phase III trial of Gra...